These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36320601)

  • 21. Influence of Peroxide Impurities in Povidone on the Stability of Selected β-Blockers with the Help of HPLC.
    Prachi S; Komal C; Priti MJ
    AAPS PharmSciTech; 2017 Oct; 18(7):2410-2417. PubMed ID: 28155135
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new approach to accelerated drug-excipient compatibility testing.
    Sims JL; Carreira JA; Carrier DJ; Crabtree SR; Easton L; Hancock SA; Simcox CE
    Pharm Dev Technol; 2003; 8(2):119-26. PubMed ID: 12760562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Assessment of Protein and Excipient Stability in Biopharmaceutical Formulations Using
    Bramham JE; Podmore A; Davies SA; Golovanov AP
    ACS Pharmacol Transl Sci; 2021 Feb; 4(1):288-295. PubMed ID: 33659867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of a solid state reaction product from a lyophilized formulation of a cyclic heptapeptide. A novel example of an excipient-induced oxidation.
    Dubost DC; Kaufman MJ; Zimmerman JA; Bogusky MJ; Coddington AB; Pitzenberger SM
    Pharm Res; 1996 Dec; 13(12):1811-4. PubMed ID: 8987076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The protective effect of lactose on lyophilization of CNK-20402.
    Lee YC; Nelson J; Sueda K; Seibert D; Hsieh WY; Braxton B
    AAPS PharmSciTech; 2005 Sep; 6(1):E42-8. PubMed ID: 16353962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Stability evaluation of thymopentin in preparation process].
    He W; Zhang Z; Jiang X; Nie Y; Wu F
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Apr; 34(2):292-4. PubMed ID: 12947717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of isotonic agents on the stability of thimerosal in ophthalmic formulations.
    Reader MJ
    J Pharm Sci; 1984 Jun; 73(6):840-1. PubMed ID: 6429316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excipient exchange in the comparison of preparations of the same biologic made by different manufacturing processes: an exploratory study with recombinant human growth hormone (rhGH).
    Cauchy M; Hefford MA
    Biologicals; 2010 Nov; 38(6):637-43. PubMed ID: 20797874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of chemical stability of sitagliptin by LC-UV, LC-MS and FT-IR methods.
    Gumieniczek A; Berecka A; Mroczek T; Wojtanowski K; Dąbrowska K; Stępień K
    J Pharm Biomed Anal; 2019 Feb; 164():789-807. PubMed ID: 30503802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Do co-spray dried excipients offer better lysozyme stabilisation than single excipients?
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Eur J Pharm Sci; 2008 Mar; 33(3):294-305. PubMed ID: 18262776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.
    Tan Y; Yang Z; Pan X; Chen M; Feng M; Wang L; Liu H; Shan Z; Wu C
    Int J Pharm; 2012 May; 427(2):385-92. PubMed ID: 22343132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of aldehydes in excipients used in liquid/semi-solid formulations by gas chromatography-negative chemical ionization mass spectrometry.
    Li Z; Kozlowski BM; Chang EP
    J Chromatogr A; 2007 Aug; 1160(1-2):299-305. PubMed ID: 17586516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Manufacturing and ambient stability of shelf freeze dried bacteriophage powder formulations.
    Zhang Y; Peng X; Zhang H; Watts AB; Ghosh D
    Int J Pharm; 2018 May; 542(1-2):1-7. PubMed ID: 29486286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a new HPLC-MS method for meglumine impurity profiling.
    Martano C; Ferretti F; Ghiani S; Buonsanti F; Bruno E; Lattuada L; Medana C
    J Pharm Biomed Anal; 2018 Feb; 149():517-524. PubMed ID: 29175747
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of Electrostatic Mediated Antibody Liquid-Liquid Phase Separation by Charged and Noncharged Preferentially Excluded Excipients.
    Banks DD; Cordia JF
    Mol Pharm; 2021 Mar; 18(3):1285-1292. PubMed ID: 33555888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of excipient interactions on solid dosage form stability.
    Narang AS; Desai D; Badawy S
    Pharm Res; 2012 Oct; 29(10):2660-83. PubMed ID: 22707362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A; Müller RH
    Pharmazie; 2006 May; 61(5):425-30. PubMed ID: 16724540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding drug-excipient compatibility: oxidation of compound A in a solid dosage form.
    Wu Y; Dali M; Gupta A; Raghavan K
    Pharm Dev Technol; 2009; 14(5):556-64. PubMed ID: 19743950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using thermal forced degradation approach for impurity profiling of budesonide solution-formulated metered dose inhalation with implementation of LC-QTOFMS and HPLC-UV.
    Peng M; Song D; Ling X; Jiang W; Zhang Y; Yang Y; Le J
    J Pharm Biomed Anal; 2022 Jan; 208():114445. PubMed ID: 34763210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.